Hashimoto tiroiditinin trombositler üzerine sayı, büyüklük ve dağılım açısından etkisi
Amaç: Çalışmamızın amacı, Hashimoto tiroiditi olan hastalarda trombosit endekslerinin etkilenip etkilenmediğiniaraştırmaktır.Yöntemler: HT'li 11 hasta (10 kadın, 1 erkek) ve kontrol grubu olarak seçilen nodüler guatrlı 26 kişi (19 kadın, 7erkek) çalışmaya dahil edildi. Tüm olguların tam kan sayımı parametreleri (lökosit sayısı, nötrofil sayısı ve yüzdesi,lenfosit sayısı ve yüzdesi, trombosit sayısı, trombosit yüzdesi, trombosit dağılım genişliği (PDW) ve ortalamatrombosit hacmi (MPV)) incelendi.Bulgular: Hasta grubunda lökosit sayısı, nötrofil sayısı ve yüzdesi, lenfosit yüzdesi, trombosit sayısı, platelet yüzdesive MPV değerleri kontrol grubundan istatistiksel olarak farklı değildi. Lenfosit sayısı ve PDW, HT'li hastalarda kontrolgrubuna göre anlamlı derecede yüksekti.Sonuç: Bulgularımız HT'li hastaların PDW düzeylerinin daha yüksek olduğunu göstermektedir. HT'de artmış PDW,hastalığın tanısı, takibi ve prognozu açısından anlamlı olabilir.
The effect of Hashimoto's thyroiditis on platelets in terms of the their number, size, and distribution
Objective: The aim of our study was to investigate whether platelet indices were affected in patients with Hashimoto’s thyroiditis (HT). Method: 11 patients (10 female, 1 male) with HT and 26 subjects with nodular goiters (19 female, 7 male) selected as control group were included in the study. All cases were examined for complete blood count parameters (leukocyte count, neutrophil count and percentage, lymphocyte count and percentage, platelet count, plateletcrit, platelet distribution width (PDW), and mean platelet volume (MPV)). Results: Leukocyte count, neutrophil count and percentage, lymphocyte percentage, platelet count, plateletcrit, and MPV in the patient group were not statistically different from the control group. Lymphocyte count and PDW were significantly higher in patients with HT than in the control group. Conclusion: Our results suggest that patients with HT have higher PDW levels. Increased PDW in HT may be helpful in diagnosis, floow-up, and prognosis of the disease.
___
- 1. Lal G, Clark OH. Textbook of endocrine surgery.
Philadelphia: Saunders; 2005.p.38–40.
- 2. Kumar V, Robbins SL. Robbins basic pathology.
Philadelphia, PA: Saunders/Elsevier; 2007:p.731–6.
- 3. Ajjan RA, Weetman AP. The pathogenesis of
Hashimoto's thyroiditis: further developments in our
understanding. Horm Metab Res 2015; 47: 702-10.
- 4. Effraimidis G, Wiersinga WM. Mechanisms in
endocrinology: autoimmune thyroid disease: old and
new players. Eur J Endocrinol 2014; 170: R241-52.
- 5. Weetman AP. Cellular immune responses in
autoimmune thyroid disease. Clin Endocrinol (Oxf)
2004; 61: 405-13.
- 6. Volpe R. Suppressor T lymphocyte dysfunction is
important in the pathogenesis of autoimmune thyroid
disease: a perspective. Thyroid 1993; 3: 345-52.
- 7. Thomas MR, Storey RF. The role of platelets in
inflammation. Thromb Haemost 2015; 114: 449-58.
- 8. Islamoğlu Y, Buyukkaya E, Kaya Z, et all. Effect of the
hematological and biochemical parameters on
outcomes of the patients with infective endocarditis.
Dicle Med J. 2011; 38: 392-7.
- 9. Kilic E, Rezvani A, Toprak AE, et all. Evaluation of
Neutrophil to Lymphocyte and Platelet to Lymphocyte
Ratios in Rheumatoid Arthritis. Dicle Med J. 2016; 43:
241-7.
- 10. Guvendi B, Kara F, Binnetoglu K, et all. Comparison of
platelet indices in papillary thyroid carcinoma and
microcarcinoma. J Turgut Ozal Med Cent. 2018; 25:
122-4.
- 11. Sit M, Kargi E, Aktas G, et all. Mean platelet volume
should be a useful indicator in diagnosis of Hashimoto’s
thyroiditis. Acta Medica Mediterranea 2014; 30: 1263-
6.
- 12. Carlioglu A, Timur O, Durmaz SA, Ayhan ME. Mean
platelet volume in euthyroid patients with Hashimoto's
thyroiditis. Blood Coagul Fibrinolysis 2015; 26: 282-4.
- 13. Savas E, Sahin AZ, Aksoy SN, et all. Serum levels of
inflammatory markers in patients with thyroid
dysfunction and their association with autoimmunity
status. Int J Clin Exp Med 2016; 9: 4485-90.
- 14. Gorbach SL, Bartlett JG, Blacklow NR. Infectious
diseases. Philadelphia: Lippincott Williams & Wilkins;
2004: 159.
- 15. Aktas G, Sit M, Dikbas O, et all. Could red cell
distribution width be a marker in Hashimoto’s
thyroiditis? Experimental and Clinical Endocrinology &
Diabetes. 2014; 122: 572-4.
- 16. Atile NS, Bilir BE, Bilir B, Guldiken S. Mean platelet
volume levels in patients with overt hypothyroidism
before and after levothyroxine treatment. Acta
Endocrinologica (Buc), 2012; 8: 607-14.
- 17. Bilge M, Adas M, Yesilova A, Helvaci A. Mean platelet
volume (MPV) and platelet distribution width (PDW) in
euthyroid woman with Hashimoto’s Thyroiditis.
Endocrine Abstracts 2016; 41: EP968.
- 18. Zhu C, Ma J, Liu Y, et all. Increased frequency of
follicular helper T cells in patients with autoimmune
thyroid disease. J Clin Endocrinol Metab 2012; 97: 943-
50.
- 19. Spolski R, Leonard WJ. IL-21 and T follicular helper
cells. Int Immunol 2010; 22: 7-12.
- 20. El-Shenawy SZ, Hemi MH, Attia H. Serum levels of
proinflammatory cytokines (interleukin 6 & interleukin
15) and adiponectin in Hashimoto’s thyroiditis with
different thyroid function states. Journal of American
Science 2011; 7: 1156-62.
- 21. Rebuffat SA, Kammoun-Krichen M, Charfeddine I, et
all. IL-1β and TSH disturb thyroid epithelium integrity
in autoimmune thyroid diseases. Immunobiology 2013;
218: 285-91.
- 22. Guan LJ, Wang X, Meng S, et all. Increased IL-21/IL21R expression and its proinflammatory effects in
autoimmune thyroid disease. Cytokine 2015; 72: 160-5.
- 23. Benbarche S, Strassel C, Angenieux C, et all. Dual role
of IL-21 in megakaryopoiesis and platelet homeostasis.
Haematologica 2017; 102: 637-46.
- 24. Cortin V, Garnier A, Pineault N, et all. Efficient in vitro
megakaryocyte maturation using cytokine cocktails
optimized by statistical experimental design. Exp
Hematol. 2005; 33: 1182–91.
- 25. Fox JG, Barthold S, Davisson M, et all. The mouse in
biomedical research: normative biology, husbandry,
and models. Amsterdam: Academic Press, 2006: 156.
- 26. Danese S, Motte Cd Cde L, Fiocchi C. Platelets in
inflammatory bowel disease: clinical, pathogenic, and
therapeutic implications. Am J Gastroenterol. 2004; 99:
938-45.